These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8178442)
1. Glycoprotein E2 of classical swine fever virus: expression in insect cells and identification as a ribonuclease. Hulst MM; Himes G; Newbigin E; Moormann RJ Virology; 1994 May; 200(2):558-65. PubMed ID: 8178442 [TBL] [Abstract][Full Text] [Related]
2. Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence. Hulst MM; van Gennip HG; Vlot AC; Schooten E; de Smit AJ; Moormann RJ J Virol; 2001 Oct; 75(20):9585-95. PubMed ID: 11559790 [TBL] [Abstract][Full Text] [Related]
3. Secreted expression of the classical swine fever virus glycoprotein E(rns) in yeast and application to a sandwich blocking ELISA. Huang C; Chien MS; Hu CM; Chen CW; Hsieh PC J Virol Methods; 2006 Mar; 132(1-2):40-7. PubMed ID: 16213600 [TBL] [Abstract][Full Text] [Related]
4. Identification of antigenic regions of the Erns protein for pig antibodies elicited during classical swine fever virus infection. Lin M; Trottier E; Pasick J; Sabara M J Biochem; 2004 Dec; 136(6):795-804. PubMed ID: 15671490 [TBL] [Abstract][Full Text] [Related]
5. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine. Risatti GR; Holinka LG; Fernandez Sainz I; Carrillo C; Kutish GF; Lu Z; Zhu J; Rock DL; Borca MV Virology; 2007 Aug; 364(2):371-82. PubMed ID: 17418362 [TBL] [Abstract][Full Text] [Related]
7. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)? van Rijn PA Vet Microbiol; 2007 Nov; 125(1-2):150-6. PubMed ID: 17561359 [TBL] [Abstract][Full Text] [Related]
8. Genetic diversity of the envelope glycoprotein E2 of classical swine fever virus: recent isolates branched away from historical and vaccine strains. Chen N; Hu H; Zhang Z; Shuai J; Jiang L; Fang W Vet Microbiol; 2008 Mar; 127(3-4):286-99. PubMed ID: 17976931 [TBL] [Abstract][Full Text] [Related]
9. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library. Peng WP; Hou Q; Xia ZH; Chen D; Li N; Sun Y; Qiu HJ Virus Res; 2008 Aug; 135(2):267-72. PubMed ID: 18485511 [TBL] [Abstract][Full Text] [Related]
10. Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice. Li M; Wang YF; Wang Y; Gao H; Li N; Sun Y; Liang BB; Qiu HJ Immunol Lett; 2009 Aug; 125(2):145-50. PubMed ID: 19589357 [TBL] [Abstract][Full Text] [Related]
11. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536 [TBL] [Abstract][Full Text] [Related]
12. The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2. Liu S; Tu C; Wang C; Yu X; Wu J; Guo S; Shao M; Gong Q; Zhu Q; Kong X J Virol Methods; 2006 Jun; 134(1-2):125-9. PubMed ID: 16455143 [TBL] [Abstract][Full Text] [Related]
13. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093 [TBL] [Abstract][Full Text] [Related]
14. Origin and evolution of viruses causing classical swine fever in Cuba. de Arce HD; Ganges L; Barrera M; Naranjo D; Sobrino F; Frías MT; Núñez JI Virus Res; 2005 Sep; 112(1-2):123-31. PubMed ID: 15878213 [TBL] [Abstract][Full Text] [Related]
15. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the RNase activity of glycoprotein E(rns) of classical swine fever virus results in a cytopathogenic virus. Hulst MM; Panoto FE; Hoekman A; van Gennip HG; Moormann RJ J Virol; 1998 Jan; 72(1):151-7. PubMed ID: 9420210 [TBL] [Abstract][Full Text] [Related]
17. Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model. Xu XG; Liu HJ Vaccine; 2008 Oct; 26(43):5455-60. PubMed ID: 18708107 [TBL] [Abstract][Full Text] [Related]
18. Dimerization of glycoprotein E(rns) of classical swine fever virus is not essential for viral replication and infection. van Gennip HG; Hesselink AT; Moormann RJ; Hulst MM Arch Virol; 2005 Nov; 150(11):2271-86. PubMed ID: 15986175 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus. Risatti GR; Holinka LG; Carrillo C; Kutish GF; Lu Z; Tulman ER; Sainz IF; Borca MV Virology; 2006 Nov; 355(1):94-101. PubMed ID: 16908042 [TBL] [Abstract][Full Text] [Related]
20. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]